| # | Drug | Count |
|---|---|---|
| 0 | IPILIMUMAB | 15 |
| 1 | NIVOLUMAB | 15 |
| 2 | CARBOPLATIN | 13 |
| 3 | IMATINIB | 13 |
| 4 | ADALIMUMAB | 10 |
| 5 | TOCILIZUMAB | 10 |
| 6 | ADALIMUMAB-AATY | 9 |
| 7 | ADALIMUMAB-ADAZ | 9 |
| 8 | ADALIMUMAB-FKJP | 9 |
| 9 | MESALAMINE | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ASCIMINIB | 5 | 0.0014 |
| 1 | DASATINIB | 6 | 0.0006 |
| 2 | CEMIPLIMAB-RWLC | 1 | 0.0005 |
| 3 | SULINDAC | 1 | 0.0004 |
| 4 | PONATINIB HYDROCHLORIDE | 2 | 0.0004 |
| 5 | IPILIMUMAB | 15 | 0.0003 |
| 6 | MESALAMINE | 9 | 0.0003 |
| 7 | SOTORASIB | 1 | 0.0003 |
| 8 | BRIGATINIB | 1 | 0.0003 |
| 9 | GILTERITINIB | 1 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CTLA-4-directed Blocking Antibody [EPC] | 15 | 0.0003 |
| 1 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 21 | 0.0002 |
| 2 | Somatostatin Analog [EPC] | 1 | 0.0001 |
| 3 | Programmed Death Ligand-1 Blocker [EPC] | 3 | 0.0001 |
| 4 | Tetracycline-class Antibacterial [EPC] | 1 | 0.0001 |
| 5 | Estrogen Receptor Antagonist [EPC] | 5 | 0.0001 |
| 6 | Glinide [EPC] | 1 | 0.0001 |
| 7 | CD30-directed Immunoconjugate [EPC] | 1 | 0.0001 |
| 8 | Aminosalicylate [EPC] | 9 | 0.0001 |
| 9 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 4 | 0.0001 |